BIA
CLB icon

Bell Investment Advisors’s Core Laboratories CLB Stock Holding History

Bell Investment Advisors’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-19
Closed – – 1751
2022
Q2 		$0 Buy
+19
New +$505 ﹤0.01% 1738
2021
Q4 		– Sell
-16
Closed – – 1797
2021
Q3 		$0 Buy
+16
New +$487 ﹤0.01% 1734

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Bell Investment Advisors's CLB Position: Q3 2022 in Review

Bell Investment Advisors sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 19 shares.

Bell Investment Advisors first reported a position in CLB in Q3 2021 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

  • Bell Investment Advisors reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
  • Bell Investment Advisors sold 19 Core Laboratories shares in Q3 2022.
  • Bell Investment Advisors first reported a position in Core Laboratories in Q3 2021 and held it in 2 quarters.
  • Bell Investment Advisors's Core Laboratories position peaked at $0 in Q2 2022.
  • 162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Bell Investment Advisors's 13F filing for Q3 2022, filed 9 Nov 2022.